PT Bundamedik Tbk (ISX:BMHS) ROCE %: 1.96% (As of Mar. 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp179.00
GF Value Rp304.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk ROCE %?

PT Bundamedik Tbk ISX:BMHS -1.65% 61 ROCE % is 1.96% as of Mar. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp304.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Bundamedik Tbk's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.96%.

PT Bundamedik Tbk  (ISX:BMHS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Bundamedik Tbk ROCE % Related Terms

PT Bundamedik Tbk ROCE % Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk ROCE % Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 26.22 9.82 3.74 3.66 3.44

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 2.24 4.50 4.41 1.96
ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk ROCE % Calculation

PT Bundamedik Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=105844.871/( ( (3446360.904 - 568415.968) + (4016429.435 - 746084.871) )/ 2 )
=105844.871/( (2877944.936+3270344.564)/ 2 )
=105844.871/3074144.75
=3.44 %

PT Bundamedik Tbk's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=64593.968/( ( (4016429.435 - 746084.871) + (4042907.843 - 721025.346) )/ 2 )
=64593.968/( ( 3270344.564 + 3321882.497 )/ 2 )
=64593.968/3296113.5305
=1.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.96% mean?
PT Bundamedik Tbk (ISX:BMHS) has a ROCE % of 1.96% as of Mar. 2026.
Is PT Bundamedik Tbk's ROCE % too high?
PT Bundamedik Tbk's current ROCE % is 1.96%. The Healthcare Providers & Services industry median ROCE % is 6.43. PT Bundamedik Tbk's value of 1.96% is 69.5% below this industry median. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's ROCE % compare to HCA and THC?
PT Bundamedik Tbk's ROCE % of 1.96% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. PT Bundamedik Tbk's value of 1.96% is 69.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current ROCE % of 1.96% is 69.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current ROCE % is 1.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp304.24, compared to a current price of Rp179.00 — trading 41.2% below its estimated fair value. The current ROCE % is 1.96% and 69.5% below the Healthcare Providers & Services industry median of 6.43. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current ROCE % is 1.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp179.00 is trading 41.2% below its estimated GF Value™ of Rp304.24. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • ROCE %: 1.96%
  • GF Value™: Rp304.24 vs. price of Rp179.00 (41.2% below fair value)
  • GF Score™: 61/100 with 4 warning signs
  • Industry Position: 69.5% below the Healthcare Providers & Services median

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp179.00
Price
Rp304.24
GF Value